Business

Disease control and tumour shrinkage observed in CHM CDH17

Disease control and tumour shrinkage observed in CHM CDH17

Chimeric Therapeutics LimitedSeptember 28, 20253

Disease control and tumour shrinkage observed in CHM CDH17

About this update from Chimeric Therapeutics Limited

Chimeric Therapeutics Ltd has released a press release. View Attachment

View stock analysis, news, and events for Chimeric Therapeutics Limited

More from Chimeric Therapeutics Limited

CHM ceases enrolment in Phase 1 trial and Company update

August 18, 2026

Chimeric receives $1.62M advance on FY26 R&D tax incentive

July 29, 2026

All Chimeric Therapeutics Limited news →